Richard Steinhart
Vermogen: 22 510 $ op 31-10-2026
Vermogen: 22 510 $ op 31-10-2026
Richard I.
Steinhart is currently an Independent Director at Atossa Therapeutics, Inc. since 2014 and an Independent Director at Actinium Pharmaceuticals, Inc. since 2013.
Formerly, Mr. Steinhart was Senior VP, Chief Financial & Accounting Officer at BioXcel Therapeutics, Inc. from 2017 to 2026; Chief Financial Officer & Vice President at Remedy Pharmaceuticals, Inc. from 2015 to 2017; CFO, Secretary, Treasurer & Senior VP-Finance at STRATA Skin Sciences, Inc. from 2012 to 2013; Independent Director at TG Therapeutics, Inc. from 2011 to 2012; Managing Director at Forest Street Capital, LLC from 1992 to 2006; Managing Director at SAE Ventures; Chief Financial Officer & Vice President at Emisphere Technologies, Inc. from 1991 to 1992; Chief Financial Officer & General Partner at CW Group, Inc. from 1991 to 1992.
Education includes undergraduate and MBAistration degrees from Pace University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-05-2026 | 10.000 ( 0,1% ) | 21 700 $ | 31-10-2026 | |
| 02-10-2026 | 316 ( 0% ) | 468 $ | 31-10-2026 | |
| 15-06-2026 | 26.335 ( 0,18% ) | 342 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 08-11-2013 |
| ATOSSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 03-03-2014 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Financieel Directeur/CFO | 31-10-2026 |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Financieel Directeur/CFO | 01-04-2017 |
| STRATA SKIN SCIENCES, INC. | Financieel Directeur/CFO | 31-12-2013 |
| TG THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2012 |
Forest Street Capital, LLC | Corporate Officer/Principal | 24-04-2006 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
TG Therapeutics, Inc.
TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc. Medical SpecialtiesHealth Technology Manufactures dermatology treatment products | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops molecule drugs for acute central nervous system disorders | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Forest Street Capital, LLC | |
SAE Ventures | |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau